Repligen Corp Earnings: Significant Revenue Growth
Repligen Corporation (NASDAQ:RGEN) reported its results for the first quarter. Repligen is a biopharmaceutical company focused primarily on the development of novel therapeutics for radiology and...
View ArticleClik here to view.
Trading Radar: 4 Healthcare Stocks’ Earnings Digested
Cardinal Health Inc. (NYSE:CAH) reported net income above Wall Street’s expectations for the third quarter. Net income for Cardinal Health Inc. rose to $333.4 million (95 cents per share) vs. $246...
View ArticleRepligen Corp Second Quarter Earnings Sneak Peek
Repligen Corporation (NASDAQ:RGEN) will unveil its latest earnings on Thursday, August 2, 2012. Repligen is a biopharmaceutical company focused primarily on the development of novel therapeutics for...
View ArticleRepligen Earnings: Beats Wall Street Expectations
Repligen Corporation (NASDAQ:RGEN) climbed to a profit in the second quarter and beat Wall Street’s expectations in the process. Repligen is a biopharmaceutical company focused primarily on the...
View ArticleRepligen Corp Third Quarter Earnings Sneak Peek
Repligen Corporation (NASDAQ:RGEN) will unveil its latest earnings on Thursday, November 8, 2012. Repligen is a biopharmaceutical company focused primarily on the development of novel therapeutics for...
View ArticleRepligen Corp. Earnings: Higher-Than-Expected Net Income
Repligen Corporation (NASDAQ:RGEN) reported net income above Wall Street’s expectations for the third quarter. Repligen is a biopharmaceutical company focused primarily on the development of novel...
View ArticleClik here to view.
MELA Sciences Director Buys 3K Shares and 4 Insider Buys to Note
Swintek Kathryn B who is Director at MELA Sciences, Inc. (NASDAQ:MELA), bought 3,000 shares at $0.79 per share for a total value of $2,370. The shares recently traded at $0.733, down $0.06, or 7.59%...
View ArticleRepligen Earnings: Here’s Why the Stock is Up Now
Repligen Corporation (NASDAQ:RGEN) delivered a profit and beat Wall Street’s expectations, AND beat the revenue expectation. The revenue beat is a positive sign to shareholders seeking high growth out...
View ArticleClik here to view.
5 Stocks Energizing Investors After Earnings
Omnicell Inc. (NASDAQ:OMCL) delivered a profit and beat Wall Street’s expectations, AND beat the revenue expectation. Adjusted Earnings Per Share increased 35% to $0.27 in the quarter versus EPS of...
View ArticleClik here to view.
Coca-Cola Supports Clean Water Initiative in Africa and 2 Other Dow Movers to...
The Coca-Cola Co. (NYSE:KO): Current price $38.68 On Wednesday at World Water Week in Stockholm, The Coca-Cola Company and Water and Sanitation for the Urban Poor announced Coke’s support of new...
View Article